跳至主要内容
临床试验/CTRI/2019/07/020070
CTRI/2019/07/020070尚未招募不适用

To Compare the efficacy and safety of Intradermal versus Intralesional Purified Protein Derivative (PPD) for treatment of Common warts in children

Himachal Pradesh University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年7月14日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1
主要终点
Not yet recruiting

研究概览

简要总结

I am going on intervention study include title to compare the efficacy and safety of Intradermal versus Intralesional Purified Protein Derivative (PPD) in treatment of Common warts in children.Dose schedule of PPD include 10TU per0.1 ml given intradermal and Intralesional at 2weekly interval upto 8weeks and asked patient to follow up at 12weeks to see resolution of warts.

研究设计

研究类型
Interventional
分配方式
Stratified randomization
盲法
Outcome Assessor Blinded

入排标准

年龄范围
5.00 Year(s) 至 15.00 Year(s)(—)
性别
All

入选标准

  • Children of age 5 to 15 years clinically diagnosed with common warts.

排除标准

  • Patients with immune suppression from any disease or drug therapy.

结局指标

主要结局

Not yet recruiting

时间窗: Not yet recruiting

次要结局

  • NA(NA)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验